SUGAR LAND--January 15, 2016--Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)--As the first quarter of 2016 gathers steam, the Pharmaceutical-Biotech Industry is projected to launch over $5 billion worth of North American projects through the end of March. A healthy cash injection of that magnitude is cause for jubilation, or at the least, cautious optimism. This robust investment of capital and maintenance dollars represents a 100% leap over the first-quarter 2015 figure of $2.5 billion. Another heartening aspect about the figures is the fact that quite a few of the first-quarter 2016 projects involve manufacturing expansions. Within this article: Details of Medicago Incorporated's vaccine production plant project in Quebec City and other pharmaceutical and biotech projects.